{"entity":{"id":"nct00998738","kind":"trial","name":"Calcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast Cancer","aka":[],"tldr":"A phase 3 trial of Ixabepilone in Breast cancer, run by Mayo Clinic, recorded as terminated on the registry.","summary":"Calcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast Cancer is a phase 3 interventional study registered as NCT00998738 by Mayo Clinic, with 1 participants recorded, started 2009-11 and due to reach its primary completion in 2010-07. Interventions recorded: Calcium Gluconate, Magnesium Sulfate, Placebo, Quality-of-Life Assessment, Questionnaire Administration, Ixabepilone. Conditions recorded: Neuropathy, Pain, Recurrent Breast Carcinoma, Stage IV Breast Cancer.\n\nLinked to the drug Ixabepilone because the registry names it among its interventions and Breast cancer among its conditions. Registry record only: no result has been read by an editor.","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT00998738","url":"https://clinicaltrials.gov/study/NCT00998738"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["breast-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["ixabepilone"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT00998738","phase":"3","setting":"The Use of Calcium and Magnesium for Prevention of Ixabepilone Induced Peripheral Neuropathy: A Phase III Double-Blind Placebo Controlled Study","sponsor":"Mayo Clinic","enrolled":1,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct00998738/","neighbours":{"cancer":[{"id":"breast-cancer","kind":"cancer","name":"Breast cancer (all types)","route":"/cancers/breast-cancer/"}],"drug":[{"id":"ixabepilone","kind":"drug","name":"Ixabepilone","route":"/drugs/ixabepilone/"}]}}